Name: Cancer Immunology and Immunotherapy: Volume 1 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy (en Inglés)
SKU: 55242968
Price: 215660.00 CLP
Availability: InStock
Author: Amiji, Mansoor M. ; Milane, Lara Scheherazade
ISBN: 9780128233979

portada Cancer Immunology and Immunotherapy: Volume 1 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy (en Inglés)

Cancer Immunology and Immunotherapy: Volume 1 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy (en Inglés)

Formato

Libro Físico

Ilustrado por

Mansoor M. Amiji

Lara Scheherazade Milane

Editorial

Academic Press

Autor

Amiji, Mansoor M. ; Milane, Lara Scheherazade

Idioma

Inglés

N° páginas

548

Encuadernación

Tapa Blanda

Dimensiones

23.4x19.1x2.8 cm

Peso

1.42 kg.

ISBN13

9780128233979

N° edición

Categorías

Industrias químicas, biotecnológicas y farmacéuticas
Epidemiología y estadística médica
Medicina preclínica: ciencias básicas
Biotecnología

Cancer Immunology and Immunotherapy: Volume 1 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy (en Inglés)

Mansoor M. Amiji (Ilustrado por) · Lara Scheherazade Milane (Ilustrado por) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 22 días háb.

$ 392.110$ 215.660

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 215.660

Llega entre el 08 Oct y el 16 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Cancer Immunology and Immunotherapy: Volume 1 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy (en Inglés)"

Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. Nanotechnology-based targeted delivery strategies could improve the delivery efficiency of IO agents as well as provide additional avenues for novel therapeutic and vaccination strategies. Additionally, a number of locally-administered immunogenic scaffolds and therapeutic strategies, such as the use of STING agonist, could benefit from rationally designed biomaterials and delivery approaches. Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side.